Trastuzumab Completed Phase 2 Trials for Metastatic Bone Sarcomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00023998Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma